Clinical Trials in China / NCT03561766
Recruiting
Observational
Birth Cohort Study of China Medical University
NCT03561766 · tracked via the Priya Life Science China tracker
Condition(s) studied
Twin; Complicating PregnancyAdvanced Maternal Age PregnancyScarred UterusOverweight and Obesity
Study summary
The CMUBCS is a birth cohort study located in Shenyang, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology. Data are collected regarding environmental factors, family and lifestyle, clinical experimental outcomes and imaging results of pregnant women and children from birth to 18 years old. Biological samples including blood and tissue samples are also collected from the children and their parents.
Eligibility
Inclusion Criteria:
1. Pregnant women, \<13 gestational weeks
2. Permanent residents or families intended to remain in Shenyang and surrounding areas
3. Pregnant women who are planned to be examined and delivered in Shengjing Hospital.
Exclusion Criteria:
1. Pregnant women who refuse to take part in the study
2. Pregnant women have diseases that might affect the results of researches, including neuropsychiatric disorders.
Primary outcome measure(s)
- Change of biometric parameter in centimeter of fetuses at the thirteenth week of gestational age — At every week from the thirteenth week of gestational age to delivery of babies
Including head circumference, abdominal circumference, biparietal diameter, femur length of singleton and twin pregnancy - Weight in kilogram of neonate — At birth of neonate
Including singleton and twin pregnancy measured by nurses - Gene expression of husbands of pregnancy women — At 13 weeks of gestational age
DNA methylation, histone acetylation etc. assessed by analyses of blood - Change of gene expression of pregnancy women — At 13, 26 and 34 weeks of gestational age
DNA methylation, histone acetylation etc. assessed by analyses of blood - Result of Non-invasive Prenatal Testing — From 12 to 22 weeks of gestational age
including singleton and twin pregnancy
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Shengjing Hospital | Shenyang | Liaoning | Recruiting |
More Shengjing Hospital trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03561766 on ClinicalTrials.gov ↗ ← All trials in China